DYN Dyne Therapeutics, Inc.
$18.21▼ -1.14%
Healthcare
Other
After hours
$18.50▲ +1.59%
Sep 11, 7:30 PM ET
Volume 3.77M
Avg Volume (10D) 3.89M
Key Metrics & Fundamentals
Market Cap
$3.40B
P/E Ratio
–
Div Yield
–%
52W Range
11.92 - 27.31
% vs 50 MA
-25.85%
% vs 200 MA
-8.42%
RSI-14
18.1
MACD Histogram
-0.9700
Beta (1Y vs SPY)
2.07
Free Cash Flow
-$131.80M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$173.40M
COGS
–
Operating Exp
$181.66M
Operating Income
-$181.66M
EBIT
-$181.66M
Pretax Income
-$178.56M
Net Income
-$178.56M
EPS (Diluted)
-1.08
Price & Volume History
Loading chart…
Recent News
Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes
Stocktwits · Sep 9, 2026 3:41 PM
Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says
MT Newswires · Sep 9, 2026 3:10 PM
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
The Fly · Sep 9, 2026 1:51 PM
JPMorgan Downgrades Dyne Therapeutics to Underweight From Neutral, Cuts Price Target to $10 From $17
MT Newswires · Sep 9, 2026 11:28 AM
RBC Cuts Price Target on Dyne Therapeutics to $30 From $35, Keeps Outperform, Speculative Risk
MT Newswires · Sep 9, 2026 10:55 AM
Novartis Stock Tanks Following Third Major Pipeline Setback
Barrons.com · Sep 8, 2026 8:26 PM
Novartis shares fall as del-desiran flunks Phase 3 myotonic dystrophy trial
Proactive · Sep 8, 2026 3:04 PM
Why the Dow is being dragged down by a Swiss company’s bad news
MarketWatch · Sep 8, 2026 12:47 PM
Top Premarket Decliners
MT Newswires · Sep 8, 2026 11:54 AM
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
GlobeNewswire · Sep 8, 2026 11:51 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DYN's money flow as a full page
Social Sentiment
Avg -0.05 · 2 posts
list of all pre-revenue companies sorted by market capitalization.
r/stocks · Sep 24, 2025
The post highlights DYN's high market cap with zero revenue and suggests a speculative run-up, indicating negative sentiment.
negative
-0.60
DiscussionDDWant to start a thread for discussion on tickers that you see having huge potential in the upcoming decade and why?
r/wallstreetbets · Oct 26, 2024
Cited for potential in the biotechnology sector
positive
+0.50
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.